Hangzhou Diagens Biotechnology Co., Ltd. (HKG:2526)

Hong Kong · Delayed Price · Currency is HKD

323.80

+36.80 (12.82%)

Jul 31, 2026, 4:08 PM HKT

HKG:2526 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Revenue	164.42	164.42	70.35	52.84
Revenue Growth	-	133.72%	33.13%	-
Gross Profit	118.09	118.09	46.06	37.5
Operating Income	-80.57	-80.57	-32.09	-44.19
Net Income	-67.14	-67.14	-43.38	-56.12
Earnings Per Share	-0.84	-0.84	-0.55	-0.74
EPS Growth	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Investments	45.46	45.46	58.6	84.53
Total Debt	5.92	5.92	19.12	4.5
Net Cash (Debt)	39.54	39.54	39.48	80.03
Net Cash Growth	-	0.16%	-50.67%	-
Net Cash Per Share	0.49	0.49	0.50	1.05

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Operating Cash Flow	-50.54	-50.54	-29.78	-47.4
Capital Expenditures	-7.47	-7.47	-24.2	-24.22
Free Cash Flow	-58	-58	-53.98	-71.61
Free Cash Flow Growth	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Gross Margin	71.82%	71.82%	65.47%	70.95%
Operating Margin	-49.00%	-49.00%	-45.62%	-83.62%
Pretax Margin	-40.83%	-40.83%	-61.67%	-106.32%
Profit Margin	-40.83%	-40.83%	-61.65%	-106.19%
FCF Margin	-35.28%	-35.28%	-76.72%	-135.52%